Sexual Health & Medical Wellness Johns Hopkins researchers develop innovative intranasal DNA vaccine to combat drug-tolerant tuberculosis October 26, 2026 Susilo Ahmad Tuberculosis (TB) remains a formidable global health crisis, persisting for over six millennia as a leading cause of mortality from a single infectious pathogen. Despite significant medical advancements, the bacterium…
Psychology & Intimacy Breakthrough Neuroinflammation Research Identifies Existing Drug Target to Combat Alzheimer’s, Parkinson’s, and Traumatic Brain Injury October 15, 2026 Rebecca Shoemaker Scientists at the University of Birmingham have unveiled a promising therapeutic pathway to mitigate harmful neuroinflammation by zeroing in on a cellular receptor that is already compatible with existing pharmacological…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters October 14, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine designed to target the persistent, drug-tolerant bacteria responsible…
Psychology & Intimacy Groundbreaking Neuroinflammation Study Identifies Existing Drug Target to Combat Brain Disorders and Neurodegeneration October 8, 2026 Rebecca Shoemaker Medical science may stand on the brink of a major therapeutic breakthrough following the publication of a new study in the academic journal Brain. Led by Professor Nicholas Barnes at…
Sexual Health & Medical Wellness Johns Hopkins researchers develop innovative intranasal DNA vaccine to combat drug-tolerant tuberculosis bacteria October 7, 2026 Susilo Ahmad A collaborative team of scientists from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health has unveiled a novel therapeutic DNA vaccine candidate designed to revolutionize the…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters September 28, 2026 Susilo Ahmad Tuberculosis remains a formidable global health crisis, persisting as one of the deadliest infectious diseases in human history despite six millennia of coexistence with our species. A team of researchers…
Sexual Health & Medical Wellness Breakthrough Intranasal DNA Vaccine Offers New Hope for Eradicating Drug-Tolerant Tuberculosis Persisters September 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine that could fundamentally shift the paradigm of tuberculosis…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Potential Game-Changer in the Global Fight Against Drug-Resistant Gonorrhea July 17, 2026 Susilo Ahmad Researchers are heralding a significant breakthrough in the treatment of gonorrhea, a widespread sexually transmitted infection, with a new oral medication named zoliflodacin demonstrating remarkable efficacy in late-stage clinical trials.…
Psychology & Intimacy Prucalopride, a Chronic Constipation Drug, Shows Promise in Alleviating Lingering Cognitive Deficits in Depression July 16, 2026 Rebecca Shoemaker People grappling with depression often find that even after their mood significantly improves, they are left with a persistent burden of cognitive challenges. These lingering symptoms can include profound memory…
